News and Events
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read MoreWith new database, NCATS data is poised to support development of precision cancer therapies
Data from thousands of compounds and nearly 200 cancer cell lines screened at the National Center for Advancing Translational Sciences are available through a new CellMiner database.
Read MoreAndre Nussenzweig elected to the National Academy of Sciences
Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, has been elected to the National Academy of Sciences in recognition of his distinguished and continuing achievements in original research. He investigates the mechanisms that maintain genomic stability and prevent cancer, particularly in DNA repair pathways.
Read MoreClinical trial researches drug therapy for prostate cancer
A clinical trial led by William Douglas Figg Sr., Pharm.D., Senior Investigator in the Genitourinary Malignancies Branch is researching a drug therapy for advanced prostate cancer.
Read MoreIn Memoriam: W. Michael Kuehl, M.D.
The CCR community is deeply saddened by the recent passing of W. Michael Kuehl, M.D., former Senior Investigator in the Genetics Branch.
Read MoreNaomi Taylor and Peter Choyke elected to the Association of American Physicians
Naomi Taylor, M.D., Ph.D., Senior Investigator in the Pediatric Oncology Branch, and Peter L. Choyke, M.D., F.A.C.R., Chief and Senior Investigator of the Molecular Imaging Branch, were elected as members of the Association of American Physicians (AAP). Each year, the AAP elects 70 new members to honor their outstanding credentials and achievements in basic or translational biomedical research.
Read MoreClinical trial researching stem cell therapy for acute myeloid leukemia
A clinical trial led by Nirali N. Shah, M.D., M.H.Sc., Lasker Clinical Research Scholar in the Pediatric Oncology Branch, is researching hematopoietic stem cell transplants and therapy for acute myeloid leukemia.
Read MoreAndre Nussenzweig and Sandra Wolin elected to American Academy of Arts and Sciences
Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, and Sandra L. Wolin, M.D., Ph.D., Chief of the RNA Biology Laboratory, have been elected to the American Academy of Arts and Sciences.
Read MoreClinical trial researching chemotherapy for bile duct cancer
A clinical trial led by Jonathan M. Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching chemotherapy for liver-only cholangiocarcinoma.
Read MoreHow immunotherapy before surgery boosts systemic immunity in head and neck cancer
Some evidence suggests that immunotherapy before surgery to remove head and neck tumors can decrease the chances of cancer recurrence, but the reasons for this observation are unknown. New research details how the treatment regimen boosts the number and dispersion of tumor-fighting immune cells throughout the body.
Read MoreClinical trial researching therapy for blood cancers
A clinical trial led by Christopher Kanakry, M.D., Lasker Clinical Research Scholar in the Center for Immuno-Oncology, is researching blood stem cell transplants for blood cancers such as leukemias or lymphomas.
Read More